Co-Diagnostics, Inc. Announces Completion Of The Acquisition Of All Assets And Intellectual Property Related To At-Home/Point-Of-Care Platform
Acquiring Company
Co-Diagnostics, Inc.
Acquired Company
Assets
Description
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the acquisition of Idaho Molecular Inc. and Advanced Conceptions, Inc. for nearly 4.72 million shares of the Company's stock, plus additional common warrants totaling 465,000, providing Co-Diagnostics with all existing and future assets and intellectual property related to the Company's upcoming at-home/point-of-care diagnostic device.
Quick answer
Co-Diagnostics, Inc. is acquiring Assets, announced December 31, 2021. Co-Diagnostics, Inc. is based in Salt Lake City, Utah, United States.
- How much did Co-Diagnostics, Inc. pay for Assets?
- The deal value was not disclosed.
- What does Co-Diagnostics, Inc. do?
- At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to..
- Where are Co-Diagnostics, Inc. and Assets based?
- Co-Diagnostics, Inc. is based in Salt Lake City, Utah, United States.
Source: Fundz verified event record.
Who to call at Co-Diagnostics, Inc., and when
When Co-Diagnostics, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Co-Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Co-Diagnostics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Co-Diagnostics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Co-Diagnostics, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Assets?
Assets was acquired by Co-Diagnostics, Inc., based in Salt Lake City. The deal was reported on December 31, 2021. Co-Diagnostics, Inc. is publicly traded (CODX) and operates in Manufacturing.
When did Co-Diagnostics, Inc. acquire Assets?
Co-Diagnostics, Inc.'s acquisition of Assets was reported on December 31, 2021. Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the acquisition of Idaho Molecular Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Assets do?
Assets is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.